Immediate Impact
74 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
2024 Standout
Works of John McLaren being referenced
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
2016
The characterisation and determinants of quality of life in ANCA associated vasculitis
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John McLaren | 175 | 151 | 82 | 10 | 290 | |
| D. Schaumann | 90 | 165 | 57 | 12 | 300 | |
| B. Brihaye | 160 | 139 | 84 | 12 | 254 | |
| Dimitrios Christidis | 175 | 175 | 64 | 9 | 291 | |
| Takeshi Umibe | 161 | 81 | 27 | 17 | 248 | |
| Adriana Sánchez-Ortíz | 194 | 52 | 28 | 12 | 284 | |
| Christian Mrowka | 87 | 127 | 32 | 10 | 284 | |
| J. Henes | 122 | 144 | 53 | 19 | 247 | |
| Paula Dospinescu | 104 | 126 | 57 | 11 | 186 | |
| Nicolò Pipitone | 189 | 194 | 48 | 10 | 304 | |
| Maria Sandberg | 169 | 54 | 18 | 14 | 336 |
All Works
Loading papers...